Business Description

Description
GelStat Corp is a consumer healthcare company operating in the US. It is engaged in the development and marketing of over-the-counter (OTC) and other non-prescription consumer healthcare products. The company's lead product is Gelstat Migraine, which is a patented OTC homeopathic drug for use as a first-line, acute treatment for migraine and migraine-like headaches. The Gelstat Migraine is developed to provide acute relief from headache pain as well as other symptoms associated with a migraine. The other products of the company include CHEWS 2 LOSE, which is a diet aide in the form of an all-natural appetite suppressant gum; All Natural Speed which targets specific quick-fix energy user groups; and GelStat Sleep, which provides relief from sleep disorders and their associated symptoms.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 16.9
9-Day RSI 28.73
14-Day RSI 35.54
6-1 Month Momentum % 100
12-1 Month Momentum % 37.93

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin % -365.22

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -0.09
EV-to-EBITDA -0.09
EV-to-Revenue 1.65
Earnings Yield (Greenblatt) % -1111.11
FCF Yield % -221.05

Financials

GSAC's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:GSAC

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

GelStat Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.023
EPS (TTM) ($) -0.03
Beta 1.06
Volatility % 212.32
14-Day RSI 35.54
14-Day ATR ($) 0.000046
20-Day SMA ($) 0.00041
12-1 Month Momentum % 37.93
52-Week Range ($) 0.0001 - 0.0017
Shares Outstanding (Mil) 524.99

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

GelStat Corp Filings

Filing Date Document Date Form
No Filing Data

GelStat Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

GelStat Corp Frequently Asked Questions

What is GelStat Corp(GSAC)'s stock price today?
The current price of GSAC is $0.00. The 52 week high of GSAC is $0.00 and 52 week low is $0.00.
When is next earnings date of GelStat Corp(GSAC)?
The next earnings date of GelStat Corp(GSAC) is .
Does GelStat Corp(GSAC) pay dividends? If so, how much?
GelStat Corp(GSAC) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1